Article
Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells.
Human gene therapy - 10 Feb 2001
Hacein-Bey S, Gross F, Nusbaum P, Hue C, Hamel Y, Fischer A, Cavazzana-Calvo M
Abstract excerpt
We have attempted to improve retrovirus-mediated gene transfer efficacy into hematopoietic progenitor cells (HPCs) without causing them to lose their lymphoid potential. Highly purified CD34(+) cells on CH-296 fibronectin fragments have been transduced with three different cytokine combinations. Murine CD2 was used as a marker gene. Transgene expression was assayed by FACS analysis shortly after transduction of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
